Nominated Oral Presentation 2
Basic Research 2 Cancer Related

[NO2-3] Identification of a novel therapeutic target for Cetuximab-resistance in oral cancer: therapeutic strategies to regulate EGFR-independent pathways

UZAWA Katsuhiro^1,2, AMELIO Antonio^3,4,5, EIZUKA Keitaro¹, SAWAI Yuki¹, TOEDA Yuriko¹, SAITO Tomoaki², KITA Akihiro², KASAMATSU Atsushi², YAMAUCHI Mitsuo³, T (1.Dept. of Oral Science, Graduate School of Medicine, Chiba Univ., Chiba, Japan, 2.Dept. of Dentistry and OMS, Chiba Univ. Hospital, Chiba, Japan, 3.Dept. of Oral and Craniofacial Health Sciences, Univ. of North Carolina at Chapel Hill, NC, USA, 4.Lineberger Comprehensive Cancer Center, Univ. of North Carolina at Chapel Hill, NC, USA, 5.Biomedical Research Imaging Center, Univ. of North Carolina at Chapel Hill, NC, USA)